title: Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects.
abstract: Preclinical studies support endogenous opioid system involvement in alcohol reinforcement and consumption; however, recent clinical trials and human laboratory studies have provided mixed findings of the effects of naltrexone (a non-selective opioid antagonist) on alcohol responses. This study used a within-subject design (n = 23) to investigate naltrexone effects (0, 50 and 100 mg qd) on subjective and psychomotor responses to alcohol (none, moderate, high) in heavy drinkers. Before alcohol administration, subjects reported decreased desire to drink alcohol when maintained on 50 mg compared with placebo naltrexone. Following alcohol administration, active naltrexone significantly increased subjective ratings of sedative, and unpleasant/sick effects and decreased ratings of liking, best effects and desire to drink. Naltrexone generally did not alter subjective or objective indicators of drunkenness. Finally, high doses of naltrexone and alcohol interacted to produce the greatest decreases in liking and best effects. Findings support the role of endogenous opioids as determinants of alcohol's effects and suggest that naltrexone may be particularly clinically useful in those treatment patients who continue to drink heavily.
authors.affiliation: Johns Hopkins University School of Medicine, Richmond, VA, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: McCaul
authors.forename: G S
authors.initials: GS
authors.lastname: Wand
authors.forename: T
authors.initials: T
authors.lastname: Eissenberg
authors.forename: C A
authors.initials: CA
authors.lastname: Rohde
authors.forename: L J
authors.initials: LJ
authors.lastname: Cheskin
mesh_terms: D000328:Adult; D000428:Alcohol Drinking / Q000188:drug therapy* / Q000503:physiopathology*; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000008:administration & dosage* / Q000009:adverse effects* / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009271:Naltrexone / Q000008:administration & dosage* / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011597:Psychomotor Performance / Q000187:drug effects* / Q000502:physiology*; D013997:Time Factors
chemical_list: D009292:Narcotic Antagonists; D000431:Ethanol; D009271:Naltrexone